Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 264

1.

Triptans for Migraine Patients With Vascular Risks: New Insights, New Options.

Leroux E, Rothrock J.

Headache. 2019 Oct;59(9):1589-1596. doi: 10.1111/head.13656. Epub 2019 Sep 30. No abstract available.

PMID:
31566723
2.

FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.

Rothrock JF, Adams AM, Lipton RB, Silberstein SD, Jo E, Zhao X, Blumenfeld AM; FORWARD Study investigative group.

Headache. 2019 Nov;59(10):1700-1713. doi: 10.1111/head.13653. Epub 2019 Sep 26.

3.

Prognosis Following Discontinuation of OnabotulinumA Therapy in "Super-responding" Chronic Migraine Patients.

Ching J, Tinsley A, Rothrock J.

Headache. 2019 Sep;59(8):1279-1285. doi: 10.1111/head.13630. Epub 2019 Sep 9.

PMID:
31498897
4.

Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study.

Young WB, Ivan Lopez J, Rothrock JF, Orejudos A, Manack Adams A, Lipton RB, Blumenfeld AM.

J Headache Pain. 2019 Feb 1;20(1):12. doi: 10.1186/s10194-018-0953-0.

5.

Effects of onabotulinumtoxinA treatment in patients with and without allodynia: results of the COMPEL study.

Young WB, Ivan Lopez J, Rothrock JF, Orejudos A, Manack Adams A, Lipton RB, Blumenfeld AM.

J Headache Pain. 2019 Jan 22;20(1):10. doi: 10.1186/s10194-018-0952-1.

6.

What Are We Missing in the Diagnostic Criteria for Migraine?

Tinsley A, Rothrock JF.

Curr Pain Headache Rep. 2018 Oct 5;22(12):84. doi: 10.1007/s11916-018-0733-1. Review.

PMID:
30291572
7.

How are registered nurse first assistants in surgery faring in the U.S.?

Rothrock JC.

J Perioper Pract. 2018 Sep;28(9):213-214. doi: 10.1177/1750458918792150. No abstract available.

PMID:
30168785
8.

Post-prophylaxis gingivitis prevention with two-step stannous fluoride dentifrice plus whitening gel sequence or chlorhexidine gluconate mouthrinse.

Garcia-Godoy C, Rothrock J, Gurich N, Anastasia MK, Gerlach RW.

Am J Dent. 2018 Jul;31(Sp Is A):18A-23A.

PMID:
30106529
9.

An academic debate: OnabotulinumtoxinA for chronic migraine: PREEMPT-derived vs "customized" dosing/injection paradigm.

Green MW, Rothrock JF.

Toxicon. 2018 Jun 1;147:116-119. doi: 10.1016/j.toxicon.2018.03.011. Epub 2018 Mar 27. Review.

PMID:
29596847
10.

Impact of Gastric Acid Induced Surface Changes on Mechanical Behavior and Optical Characteristics of Dental Ceramics.

Kulkarni A, Rothrock J, Thompson J.

J Prosthodont. 2018 Jan 14. doi: 10.1111/jopr.12716. [Epub ahead of print]

PMID:
29333707
11.

Effect of Two-minute Application of 35% Sodium Ascorbate on Composite Bond Strength following Bleaching.

Ismail EH, Kilinc E, Hardigan PC, Rothrock JK, Thompson JY, Garcia-Godoy C.

J Contemp Dent Pract. 2017 Oct 1;18(10):874-880.

PMID:
28989123
12.

Inpatient versus Outpatient Management of TIA or Minor Stroke: Clinical Outcome.

Majidi S, Leon Guerrero CR, Burger KM, Rothrock JF.

J Vasc Interv Neurol. 2017 Jun;9(4):49-53.

13.

Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine.

Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Korbee LL, Porter LL, Hershey AD; CHAMP Investigators.

N Engl J Med. 2017 Jan 12;376(2):115-124. doi: 10.1056/NEJMoa1610384. Epub 2016 Oct 27.

14.

Cerebral Sinus Thrombosis.

Agrawal K, Burger K, Rothrock JF.

Headache. 2016 Sep;56(8):1380-9. doi: 10.1111/head.12873. Epub 2016 Jun 28. Review.

PMID:
27350588
15.

Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.

Kwon HM, Lynn MJ, Turan TN, Derdeyn CP, Fiorella D, Lane BF, Montgomery J, Janis LS, Rumboldt Z, Chimowitz MI; SAMMPRIS Investigators.

JAMA Neurol. 2016 Jan;73(1):36-42. doi: 10.1001/jamaneurol.2015.3145.

16.

Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.

Amory CF, Levine SR, Brey RL, Gebregziabher M, Tuhrim S, Tilley BC, Simpson AC, Sacco RL, Mohr JP; APASS-WARSS Collaborators.

Cerebrovasc Dis. 2015;40(5-6):293-300. doi: 10.1159/000441362. Epub 2015 Oct 29.

17.

2015-2016 Headache Assistant Editors.

Rothrock JF.

Headache. 2015 Sep;55(8):1051. doi: 10.1111/head.12638. Epub 2015 Aug 12. No abstract available.

PMID:
26263845
18.

Hemiplegia and headache: a review of hemiplegia in headache disorders.

Lopez JI, Holdridge A, Rothrock JF.

Curr Pain Headache Rep. 2015;19(2):471. doi: 10.1007/s11916-014-0471-y. Review.

PMID:
25501955
19.

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

Rothrock JF, Bloudek LM, Houle TT, Andress-Rothrock D, Varon SF.

Headache. 2014 Nov-Dec;54(10):1565-73. doi: 10.1111/head.12456. Epub 2014 Oct 9.

20.

Headaches caused by vascular disorders.

Rothrock JF.

Neurol Clin. 2014 May;32(2):305-19. doi: 10.1016/j.ncl.2013.11.003. Epub 2014 Feb 2. Review.

PMID:
24703533

Supplemental Content

Loading ...
Support Center